{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:46:02Z","timestamp":1793907962326,"version":"4.8.0"},"reference-count":56,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2026,2,11]]},"DOI":"10.1080\/17576180.2026.2664206","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:36:08Z","timestamp":1777534568000},"page":"313-324","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Biosimilars in practice: best-practice immunogenicity assessment and switching\/interchangeability strategies for pharmacy-led programs"],"prefix":"10.1080","volume":"18","author":[{"given":"Khawla","family":"Abouhait","sequence":"first","affiliation":[{"name":"Al Ain University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Z.","family":"Al Meslamani","sequence":"additional","affiliation":[{"name":"Al Ain University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"Cleveland Clinic. Biologics (biologic medicine). Medical Treatments; 2024."},{"key":"e_1_3_5_4_1","unstructured":"Crohn & Colitis Foundation. Biosimilars: what you should know. 2024."},{"key":"e_1_3_5_5_1","unstructured":"Association for Accessible Medicines. The U.S. Generic & biosimilar Medicines savings report. 2023."},{"key":"e_1_3_5_6_1","unstructured":"Association for Accessible Medicines. The U.S. Generic & biosimilar savings report. 2024."},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292231"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1836"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.23.00309"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw138"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1179\/2047480615Z.000000000329"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab100"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2022.2041082"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02303-1"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14228179"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa364"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241301887"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01610-1"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2025.01.206"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002560"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001988"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.11144\/Javeriana.SCSI30.sisf"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae020.015"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1581153"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18060908"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107224"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/03946320251319379"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07352-y"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.123"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.970165"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jpr3.70036"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01152-4"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-025-09971-w"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-01003-8"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2022-003571"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000536"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.21316"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199616"},{"key":"e_1_3_5_39_1","unstructured":"Blue Shield of California. Measurement of serum antibodies to selected biologic agents. 2024."},{"key":"e_1_3_5_40_1","unstructured":"FDA. Immunogenicity testing of therapeutic protein products \u2014 developing and validating assays for anti-drug antibody detection. Final. 2019."},{"key":"e_1_3_5_41_1","unstructured":"ASHP Foundation. Biosimilar implementation strategies: survey results and practice insights. 2022."},{"key":"e_1_3_5_42_1","unstructured":"National Alliance of healthcare purchaser coalitions. Employer playbook on biosimilar. 2024."},{"key":"e_1_3_5_43_1","unstructured":"Deliverable D2.4. Best practices for the implementation of governance models. 2025."},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.24926\/iip.v15i1.5922"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-024-00541-y"},{"key":"e_1_3_5_46_1","unstructured":"FDA. Labeling for biosimilar and interchangeable biosimilar products guidance for industry draft guidance. 2023."},{"key":"e_1_3_5_47_1","unstructured":"Pfizer Inc. Operationalizing biosimilars best practices: 3 practical steps toward implementation. Pfizer Inc. 2022."},{"key":"e_1_3_5_48_1","volume-title":"Statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU","author":"European Medicines Agency (EMA)","year":"2023","unstructured":"European Medicines Agency (EMA). Statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU. Amsterdam, Netherlands: European Medicines Agency; 2023."},{"key":"e_1_3_5_49_1","unstructured":"US FDA. Considerations in demonstrating interchangeability with a reference product: update [Internet]. 2024 [cited 2025 Oct 29]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/considerations-demonstrating-interchangeability-reference-product-update"},{"key":"e_1_3_5_50_1","unstructured":"FDA U. Scientific considerations in demonstrating biosimilarity to a reference product: updated recommendations for assessing the need for comparative efficacy studies [Internet]. 2025 [cited 2025 Dec 28]. Available from: https:\/\/www.fda.gov\/media\/189366\/download"},{"key":"e_1_3_5_51_1","unstructured":"GS1. Healthcare traceability and GS1 standards [Internet]. 2025 [cited 2026 Jan 23]. Available from: https:\/\/www.gs1.org\/industries\/healthcare\/traceability"},{"key":"e_1_3_5_52_1","unstructured":"European Medicines Agency (EMA). No data analysis and real world interrogation network (DARWIN EU) [Internet]. 2025 [cited 2025 Nov 6]. Available from: https:\/\/www.ema.europa.eu\/en\/about-us\/how-we-work\/data-regulation-big-data-other-sources\/real-world-evidence\/data-analysis-real-world-interrogation-network-darwin-eu"},{"key":"e_1_3_5_53_1","unstructured":"Informatics OHDS. Standardized data: the OMOP common data model [Internet]. 2025 [cited 2025 Nov 12]. Available from: https:\/\/www.ohdsi.org\/data-standardization\/"},{"key":"e_1_3_5_54_1","unstructured":"US FDA. FDA\u2019s Sentinel Initiative [Internet]. 2024 [cited 2025 Nov 12]. Available from: https:\/\/www.fda.gov\/safety\/fdas-sentinel-initiative"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00891-6"},{"key":"e_1_3_5_56_1","unstructured":"Agency MAH product R. MedSafetyWeek November 2022: every yellow card report helps to improve patient safety [Internet]. 2022 [cited 2026 Jan 23]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/6357e8898fa8f557d85b7c58\/Oct-2022-DSU-PDF.pdf"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00518-0"},{"key":"e_1_3_5_58_1","unstructured":"Health C. CVS caremark accelerates biosimilars adoption through formulary changes [Internet]. 2024 [cited 2026 Jan 23]. Available from: https:\/\/www.cvshealth.com\/news\/pbm\/cvs-caremark-accelerates-biosimilars-adoption-through-formulary-changes.html"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2026.2664206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:41:57Z","timestamp":1777902117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17576180.2026.2664206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,11]]}},"alternative-id":["10.1080\/17576180.2026.2664206"],"URL":"https:\/\/doi.org\/10.1080\/17576180.2026.2664206","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}